[1]
N. SULASHVILI, “MANIFESTATION OF THE PARTICULARITIES OF SOME KEY ISSUE ASPECTS OF NEW IMMUNOTHERAPY CHALLENGES AND PERSPECTIVES BY CAR-T CELL THERAPY”, jecmg, no. 4, pp. 119–121, Sep. 2024.